Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 July 2021 | Story Rulanzen Martin | Photo Supplied
For Prof Anthea van Jaarsveld, the balance between science, theoretical and practical experience is important for a balanced industry.

Her unique approach to Drama and Theatre Arts makes Prof Anthea van Jaarsveld the most suitable person to take over the reins as Head of the UFS Department of Drama and Theatre Arts. Prof Van Jaarsveld was officially appointed as head of this special department this year. 

The Department of Drama at the UFS is one of the biggest in the country, and according to Prof Van Jaarsveld it is also the best, because the department produces some of the finest in the industry. Her main goal as head of department is to bring about a subtle change in emphasis that will ultimately make a real contribution to employability, a greater variety of job opportunities, and practice-orientated research. “My ultimate goal is therefore an approach within which academy and practice will find each other for the benefit of both,” says Prof Van Jaarsveld.

Science, theatre and drama collide 

Prof Van Jaarsveld has a scientific approach to drama and theatre arts. She never acted professionally. It is precisely from a scientific perspective that her knowledge of the theorising and contextualisation of drama text, theatre concepts, and the film industry is applied in order to maintain a balance in a profession where the emphasis on practical experience is overwhelming.  

She studied Drama at the UFS and was also employed as Drama teacher at Eunice Girls’ School. Following this, she started working as lecturer in the Department of Afrikaans and Dutch. “There I focused on the Drama genre in Afrikaans; therefore, I never actually left drama and theatre,” says Prof Van Jaarsveld. In 2018, she returned to the Department of Drama. 

Upon her return to the department where she started her studies, her aim is to ensure that the department again complies with the total package of the UFS and to make sure “that our students are prepared for a multifaceted and dynamic industry on a practical level”. 

Prof Van Jaarsveld took over from Prof Nico Luwes who retired in 2019. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept